End of Aid: The U.S.-Israel Alliance Enters a Paid Era
In an interview with Fox News on November 3, Trump stated that U.S. annual aid to Israel—approximately $4 billion—would cease after the end of this year.
Trump said the two sides had reached an agreement “several months ago,” citing Israel’s status as a “very successful country” no longer requiring such assistance. He also emphasized that the United States would continue to provide support if needed and that Israel could still purchase U.S.-made weapons without restriction.
The current framework stems from a 10-year memorandum of understanding between the U.S. and Israel signed in 2016, providing roughly $3.8 billion annually for fiscal years 2019–2028, including about $3.3 billion in Foreign Military Financing and approximately $500 million for missile defense.
The discrepancy between Trump’s reference to “about $4 billion” and the memorandum’s figure of “$3.8 billion” remains unclarified, and the exact scope of what is included requires further verification.
This is not merely a case of “cutting off dependency”—it marks a structural shift in U.S.-Israel relations.
Nétanyahu has repeatedly expressed, throughout the year, his desire to gradually reduce and ultimately eliminate annual U.S. military aid over the next decade, transforming the bilateral relationship from one of donor and recipient into a partnership. Trump’s announcement to accelerate implementation by the end of 2026 aligns with his longstanding transactional foreign policy approach: reducing U.S. foreign outlays while preserving Israel’s ability to procure American weapons, engage in joint research and development, and maintain intelligence cooperation.
A more likely trajectory is a reduction in direct grants, but continued engagement in arms sales, joint R&D, missile defense collaboration, intelligence sharing, and wartime support will not be eliminated altogether. Israel remains highly dependent on U.S.-supplied advanced fighter aircraft, munitions, missile defense components, and wartime logistics infrastructure.
Three key uncertainties remain regarding the termination of aid by year-end.
1. Congressional procedures are incomplete. While the current aid arrangement is not a treaty, Congress has authorized funding extensions through fiscal year 2028. Whether it can be terminated prematurely before the end of this year depends on coordination between the White House and Congress.
2. Funding definitions remain unclear. It is not yet disclosed whether Trump’s figure of $4 billion includes missile defense, joint R&D, or emergency supplemental appropriations.
3. Israeli authorities have not formally confirmed the full terms. As of November 3, the Israeli government had not publicly validated all details of the agreement.
Substantial Implications
For the United States, this move represents a strategic step toward reducing foreign aid expenditures and alleviating domestic political pressures. For Israel, it offers an opportunity to decrease reliance on congressional appropriations and strengthen fiscal autonomy. However, for the broader Middle East region, annual military assistance carries strong symbolic weight; mismanagement could be interpreted as a weakening of U.S. security commitments, potentially triggering strategic miscalculations.
In the short term, the U.S.-Israel military alliance is unlikely to collapse. But over the long term, the relationship is shifting—from one where the U.S. funds and Israel consumes, to one where Israel pays, the U.S. supplies arms, and both parties co-develop capabilities. What truly warrants close attention is whether, after the cessation of aid, the U.S. will replace it through new long-term security agreements, joint funding mechanisms, or revised arms export arrangements to sustain its security commitment to Israel.
Original: toutiao.com/article/1880855890838538/
Disclaimer: The views expressed in this article are those of the author alone.